Literature DB >> 16648845

Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C.

Michelle J Hayes1, Yuu Kimata, Samantha L Wattam, Catherine Lindon, Guojie Mao, Hiroyuki Yamano, Andrew M Fry.   

Abstract

The temporal control of mitotic protein degradation remains incompletely understood. In particular, it is unclear why the mitotic checkpoint prevents the anaphase-promoting complex/cyclosome (APC/C)-mediated degradation of cyclin B and securin in early mitosis, but not cyclin A. Here, we show that another APC/C substrate, NIMA-related kinase 2A (Nek2A), is also destroyed in pro-metaphase in a checkpoint-independent manner and that this depends on an exposed carboxy-terminal methionine-arginine (MR) dipeptide tail. Truncation of the Nek2A C terminus delays its degradation until late mitosis, whereas Nek2A C-terminal peptides interfere with APC/C activity in an MR-dependent manner. Most importantly, we show that Nek2A binds directly to the APC/C, also in an MR-dependent manner, even in the absence of the adaptor protein Cdc20. As similar C-terminal dipeptide tails promote direct association of Cdc20, Cdh1 and Apc10-Doc1 with core APC/C subunits, we propose that this sequence also allows a substrate, Nek2A, to directly bind the APC/C. Thus, although Cdc20 is required for the degradation of Nek2A, it is not required for its recruitment and this renders its degradation insensitive to the mitotic checkpoint.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648845     DOI: 10.1038/ncb1410

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  86 in total

1.  Ubiquitination of Cdc20 by the APC occurs through an intramolecular mechanism.

Authors:  Ian T Foe; Scott A Foster; Stephanie K Cheung; Steven Z DeLuca; David O Morgan; David P Toczyski
Journal:  Curr Biol       Date:  2011-11-10       Impact factor: 10.834

Review 2.  Structural insights into anaphase-promoting complex function and mechanism.

Authors:  David Barford
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-27       Impact factor: 6.237

3.  APC/C(Cdc20) targets E2F1 for degradation in prometaphase.

Authors:  Melissa J Peart; Masha V Poyurovsky; Elizabeth M Kass; Marshall Urist; Emmy W Verschuren; Matthew K Summers; Peter K Jackson; Carol Prives
Journal:  Cell Cycle       Date:  2010-10-26       Impact factor: 4.534

4.  Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C.

Authors:  Katharine L Sackton; Nevena Dimova; Xing Zeng; Wei Tian; Mengmeng Zhang; Timothy B Sackton; Johnathan Meaders; Kathleen L Pfaff; Frederic Sigoillot; Hongtao Yu; Xuelian Luo; Randall W King
Journal:  Nature       Date:  2014-08-24       Impact factor: 49.962

5.  Gene copy number variation spanning 60 million years of human and primate evolution.

Authors:  Laura Dumas; Young H Kim; Anis Karimpour-Fard; Michael Cox; Janet Hopkins; Jonathan R Pollack; James M Sikela
Journal:  Genome Res       Date:  2007-07-31       Impact factor: 9.043

6.  A role for Cdc2- and PP2A-mediated regulation of Emi2 in the maintenance of CSF arrest.

Authors:  Qiju Wu; Yanxiang Guo; Ayumi Yamada; Jennifer A Perry; Michael Z Wang; Marito Araki; Christopher D Freel; Jeffrey J Tung; Wanli Tang; Seth S Margolis; Peter K Jackson; Hiroyuki Yamano; Maki Asano; Sally Kornbluth
Journal:  Curr Biol       Date:  2007-02-06       Impact factor: 10.834

Review 7.  Cubism and the cell cycle: the many faces of the APC/C.

Authors:  Jonathon Pines
Journal:  Nat Rev Mol Cell Biol       Date:  2011-06-02       Impact factor: 94.444

Review 8.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

Review 9.  The multiple layers of ubiquitin-dependent cell cycle control.

Authors:  Katherine Wickliffe; Adam Williamson; Lingyan Jin; Michael Rape
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

10.  Activation of the APC/C ubiquitin ligase by enhanced E2 efficiency.

Authors:  Vanessa A Van Voorhis; David O Morgan
Journal:  Curr Biol       Date:  2014-06-12       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.